Public Notice – November 6, 2021
Labrador-Grenfell Health is advising the public it will be offering a booster COVID-19 vaccine dose to eligible individuals starting the week of November 8, 2021. These changes are based on guidance from the National Advisory Committee on Immunization (NACI).
A booster dose of an mRNA COVID-19 vaccine will be available to the groups listed below and must be received six months after second dose of two-dose series vaccine (Pfizer-BioNTech, Moderna, or AstraZeneca/COVISHIELD) or six months after completion of one dose vaccine (Janssen):
- Adults living in long-term care or other congregate settings that provide care for seniors;
- Adults 70 years of age and older;
- Individuals who have only received two doses of the AstraZeneca /COVISHIELD vaccine or one dose of the Janssen vaccine;
- Adults who identify as Indigenous or who live in an Indigenous community; and
- Adults who are frontline health-care workers who have direct in-person contact with patients and who were vaccinated with a very short interval (less than 28 days).
Currently, there are no booster dose recommendations for individuals who are unable to receive an mRNA vaccine.
Labrador-Grenfell Health will continue to offer a third dose of mRNA vaccine to individuals who self-identify as moderately to severely immunocompromised. The minimum interval between doses for these individuals is 28 days.
Information on how to book an appointment in your community can be found on our COVID-19 Vaccine Portal at https://www.lghealth.ca/vaccine .
The public is reminded that they should not schedule an appointment for a vaccine if they are experiencing symptoms of COVID-19. Instead, they should complete a COVID-19 Assessment.
For more information on COVID-19 vaccines, please visit Health Canada. For up-to-date information around the provincial COVID-19 pandemic plan, please visit www.gov.nl.ca/covid-19.
Media Contact:
Amanda MacNeil
Regional Director of Communications, Labrador-Grenfell Health